SAFE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
SAFE is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some short-term technical strength, but the overall setup is mixed: analysts are lowering targets, hedge funds are heavily selling, there is no recent positive news catalyst, and options positioning is bearish. Because the user is impatient and does not want to wait for an ideal entry, I would still not recommend buying aggressively here. The better call is to hold off for now.
Technically, SAFE is in a short-term bullish structure. MACD histogram is positive and expanding, RSI-6 is 64.77, and the moving averages are aligned bullishly with SMA_5 > SMA_20 > SMA_200. Price at 16.37 is near the first resistance zone (R1 16.317) and below R2 at 16.663, while pivot support sits at 15.755. This suggests near-term upward momentum, but the stock is not showing a compelling breakout entry. The pattern probability data also suggests only modest upside over the next week and month.
["Short-term technical trend is positive: MACD improving and moving averages aligned bullishly.", "Price is holding above the pivot and above key support levels.", "Goldman Sachs still keeps a Buy rating despite lowering the target."]
["Goldman Sachs cut the price target from $27 to $23.", "RBC downgraded the stock to Sector Perform and cut target to $16.", "Hedge funds are selling heavily, with selling accelerating sharply last quarter.", "No fresh news catalysts in the last week.", "Options open interest is heavily put-skewed.", "No recent insider accumulation and no recent congress trading data."]
No usable latest-quarter financial snapshot was provided because of a data error, so I cannot assess revenue or earnings growth directly. Since the latest quarter season is not available in the dataset, I cannot confirm quarterly financial momentum from the provided financials.
Recent analyst trend is weakening. Goldman Sachs lowered its target to $23 from $27 but kept Buy, while RBC downgraded SAFE to Sector Perform from Outperform and lowered its target to $16, citing litigation overhang, uncertainty around the 50th St asset, and higher funding costs. Wall Street is therefore split, but the direction of revisions is negative overall, with the most recent changes showing reduced confidence and limited upside versus the current price.
